Am J Ther. 2004 Mar-Apr;11(2):141-3.

Cyclooxygenase-2 inhibitors in glioma therapy.

Source

University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA.

Abstract

The cyclooxygenase enzyme is a prostaglandin synthase that has two isoforms, cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). Upregulation of the COX-2 isoform in many cancers has led to investigation regarding the potential role of this enzyme in oncogenesis. The Food and Drug Administration has approved celecoxib (Celebrex) for patients with familial adenomatous polyposis (FAP) based on a study that showed a reduction in the number of polyps in such patients when treated with high doses of this drug. We are investigating the potential role of COX-2 inhibitors in the treatment of recurrent malignant gliomas in combination with retinoids. In this article the rationale for using this combination therapy in patients with malignant gliomas is presented.

PMID:: 14999366; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

CELECOXIB - HSDB

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Review Approach to angiogenesis inhibition based on cyclooxygenase-2. [Cancer J. 2001]
Review Approach to angiogenesis inhibition based on cyclooxygenase-2.
Masferrer J. Cancer J. 2001 Nov-Dec; 7 Suppl 3:S144-50.
Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. [Cancer Res. 2000]
Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, Seyfried NT, Abe T, Chen LB, Carroll RS, et al. Cancer Res. 2000 Sep 1; 60(17):4926-31.
Review Selective COX-2 inhibitors as chemopreventive and therapeutic agents. [Drugs Today (Barc). 2003]
Review Selective COX-2 inhibitors as chemopreventive and therapeutic agents.
Grossman HB. Drugs Today (Barc). 2003 Mar; 39(3):203-12.
Review Cyclooxygenase 2: a molecular target for cancer prevention and treatment. [Trends Pharmacol Sci. 2003]
Review Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
Subbaramaiah K, Dannenberg AJ. Trends Pharmacol Sci. 2003 Feb; 24(2):96-102.
Review [Specific inhibitors of cyclooxygenase-2 (COX-2): current knowledge and perspectives]. [Acta Biomed Ateneo Parmense. 2...]
Review [Specific inhibitors of cyclooxygenase-2 (COX-2): current knowledge and perspectives].
Rioda WT, Nervetti A. Acta Biomed Ateneo Parmense. 2001; 72(3-4):55-64.

See reviews... See all...

Cited by 2 PubMed Central articles

The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. [Nutr Metab (Lond). 2010]
The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma.
Stafford P, Abdelwahab MG, Kim do Y, Preul MC, Rho JM, Scheck AC. Nutr Metab (Lond). 2010 Sep 10; 7:74. Epub 2010 Sep 10.
Prostaglandin E2 released from activated microglia enhances astrocyte proliferation in vitro. [Toxicol Appl Pharmacol. 2009]
Prostaglandin E2 released from activated microglia enhances astrocyte proliferation in vitro.
Zhang D, Hu X, Qian L, Wilson B, Lee C, Flood P, Langenbach R, Hong JS. Toxicol Appl Pharmacol. 2009 Jul 1; 238(1):64-70. Epub 2009 May 3.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cyclooxygenase-2 inhibitors in glioma therapy.
Cyclooxygenase-2 inhibitors in glioma therapy.
Am J Ther. 2004 Mar-Apr ;11(2):141-3.

PubMed
The 1991 Borden Award Lecture. Selected aspects of intraluminal and intracellula...
The 1991 Borden Award Lecture. Selected aspects of intraluminal and intracellular phases of intestinal fat absorption.
Can J Physiol Pharmacol. 1992 Apr ;70(4):413-9.

PubMed
Model of nonalcoholic steatohepatitis.
Model of nonalcoholic steatohepatitis.
Am J Clin Nutr. 2004 Mar ;79(3):502-9.

PubMed
Astaxanthin and canthaxanthin are potent antioxidants in a membrane model.
Astaxanthin and canthaxanthin are potent antioxidants in a membrane model.
Arch Biochem Biophys. 1992 Sep ;297(2):291-5.

PubMed
The effects of smoking on estradiol metabolism.
The effects of smoking on estradiol metabolism.
Minerva Ginecol. 2004 Feb ;56(1):105-14.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Cyclooxygenase-2 inhibitors in glioma therapy.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information